Sekundære maligniteter Myelodysplasi / akut myeloid leukæmi (AML) er blevet rapporteret hos 5 ud af 211 patienter, som modtog Zevalin- behandling.
Secondary malignancies Myelodysplasia/ acute myeloid leukaemia (AML) has been reported in five out of 211 patients assigned to treatment with Zevalin.